People | January 05, 2022
Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
It plans to deliver over 300 million doses to the Indian government
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
The company will market it under the brand name Molflu
The company has developed the API in house at its R&D center in Hyderabad
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
He has over 22 years of experience in pharmaceutical sales & business development
The proposed scheme to include low-income NRIs under Ayushman Bharat (PM-JAY) would ensure life-long coverage for each individual along with their spouses
Vakrangee through its Nextgen Kendras and BharatEasy Mobile Superaap will now be able to provide medicines & healthcare services in remote areas of the country
Subscribe To Our Newsletter & Stay Updated
